CAS 737789-87-6

General Information

Relugolix, sold under the brand names Orgovyx and Relumina and as one component of Myfembree, is a gonadotropin-releasing hormone antagonist medication which is used in the treatment of prostate cancer in men and uterine fibroids in women.

Relugolix is a novel non-peptide antagonist and a thienopyrimidine derivative.

About the API

Technology Synthetic
Molecular Formula C29H27F2N7O5S
Therapeutic category Oncology
Available formulations Oral Solid